Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Panchsheel OrganicsBOM:531726 -1.39%70 Return-on-Tangible-Equity is 4.83% as of Mar. 2026, which is 66% below its 10-year median of 14.15. GuruFocus rates BOM:531726 with a GF Score™ of 70/100 and a GF Value™ of ₹170.04 (Possible Value Trap). The stock has 5 warning signs investors should review. Among 899 Drug Manufacturers companies, Panchsheel Organics ranks worse than 50.06% on this metric.
Return-on-Tangible-Equity is calculated as Net Income divided by its average total shareholder tangible equity. Total shareholder tangible equity equals to Total Stockholders Equity minus Intangible Assets. Panchsheel Organics's annualized net income for the quarter that ended in Mar. 2026 was ₹68 Mil. Panchsheel Organics's average shareholder tangible equity for the quarter that ended in Mar. 2026 was ₹1,408 Mil. Therefore, Panchsheel Organics's annualized Return-on-Tangible-Equity for the quarter that ended in Mar. 2026 was 4.83%.
The historical rank and industry rank for Panchsheel Organics's Return-on-Tangible-Equity or its related term are showing as below:
BOM:531726'
s Return-on-Tangible-Equity Range Over the Past 10 Years
Min: 7.87 Med: 14.15 Max: 19.61
Current: 7.87
During the past 13 years, Panchsheel Organics's highest Return-on-Tangible-Equity was 19.61%. The lowest was 7.87%. And the median was 14.15%.
BOM:531726's Return-on-Tangible-Equity is ranked worse than 50.06% of 899
companies
in the Drug Manufacturers industry
Industry Median: 7.87
vs BOM:531726: 7.87
Return-on-Tangible-Equity measures the rate of return on the ownership interest (shareholder's tangible equity) of the common stock owners. It measures a firm's efficiency at generating profits from every unit of shareholders' tangible equity (shareholders equity minus intangibles). Return-on-Tangible-Equity shows how well a company uses investment funds to generate earnings growth. Return-on-Tangible-Equitys between 15% and 20% are considered desirable.
Be Aware
Net Income is used.
Because a company can increase its Return-on-Tangible-Equity by having more financial leverage, it is important to watch the leverage ratio when investing in high Return-on-Tangible-Equity companies. Like Return-on-Tangible-Asset, Return-on-Tangible-Equity is calculated with only 12 months data. Fluctuations in company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective.
Asset light businesses require very few assets to generate very high earnings. Their Return-on-Tangible-Equitys can be extremely high.
Panchsheel Organics Return-on-Tangible-Equity Related Terms
Panchsheel Organics Return-on-Tangible-Equity Historical Data
* Premium members only.
The historical data trend for Panchsheel Organics's Return-on-Tangible-Equity can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BOM:531726 vs ZTS: Return-on-Tangible-Equity Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Panchsheel Organics's Return-on-Tangible-Equity, along with its competitors' market caps and Return-on-Tangible-Equity data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Panchsheel Organics Return-on-Tangible-Equity vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Panchsheel Organics's Return-on-Tangible-Equity distribution charts can be found below:
* The bar in red indicates where Panchsheel Organics's Return-on-Tangible-Equity falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
In the calculation of annual Return-on-Tangible-Equity, the net income of the last fiscal year and the average total shareholder tangible equity over the fiscal year are used. In calculating the quarterly data,
the net income data used here is four times the quarterly (Mar. 2026) net income data.
Return-on-Tangible-Equity is displayed in the 10-year financial page.
What does a Return-on-Tangible-Equity of 4.83% mean?
Panchsheel Organics (BOM:531726) has a Return-on-Tangible-Equity of 4.83% as of Mar. 2026. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Panchsheel Organics and its competitors. This is 66% below median its historical median of 14.15. Over the past decade, Panchsheel Organics' Return-on-Tangible-Equity has ranged from 7.87 to 19.61. According to the industry distribution chart, Panchsheel Organics ranks #450 out of 899 companies in the Drug Manufacturers industry, placing it in the top 50.1%.
Is Panchsheel Organics' Return-on-Tangible-Equity too high?
Panchsheel Organics' current Return-on-Tangible-Equity of 4.83% is 66% below median its 10-year median of 14.15. Over the past 10 years, this metric has ranged from a low of 7.87 to a high of 19.61. The Drug Manufacturers industry median Return-on-Tangible-Equity is 7.87. Panchsheel Organics' value of 4.83% is 38.6% below this industry median. Based on the distribution chart, Panchsheel Organics ranks #450 out of 899 companies in the Drug Manufacturers industry, which is below the industry midpoint. Overall, Panchsheel Organics has a GF Score™ of 70/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Panchsheel Organics' Return-on-Tangible-Equity compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Panchsheel Organics ranks #450 out of 899 companies for Return-on-Tangible-Equity. This places Panchsheel Organics in the lower half of its industry. The industry median Return-on-Tangible-Equity is 7.87. Panchsheel Organics' value of 4.83% is 38.6% below this benchmark. Historically, Panchsheel Organics' own Return-on-Tangible-Equity has ranged from 7.87 to 19.61 over the past decade. While the company's 10-year median is 14.15 vs. the industry median of 7.87, Panchsheel Organics has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Return-on-Tangible-Equity for a Drug Manufacturers company?
The median Return-on-Tangible-Equity among Drug Manufacturers companies is 7.87, based on 899 companies in the industry. Companies in the top quartile (top 25%) have a Return-on-Tangible-Equity significantly above this median, while those in the bottom quartile fall well below. However, Return-on-Tangible-Equity should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Panchsheel Organics's current Return-on-Tangible-Equity of 4.83% is 38.6% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Return-on-Tangible-Equity mean?
A high Return-on-Tangible-Equity can signal that a stock is expensive relative to its fundamentals. Return on tangible equity is the ratio of current-period net income to average two-period tangible equity. View historical data on Panchsheel Organics and its competitors. For the Drug Manufacturers industry, the median Return-on-Tangible-Equity is 7.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Panchsheel Organics's current Return-on-Tangible-Equity is 4.83%, which is 66% below median its own 10-year median of 14.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Panchsheel Organics stock overvalued right now?
Based on GuruFocus' analysis, Panchsheel Organics (BOM:531726) is currently considered Possible Value Trap. The stock's GF Value™ is ₹170.04, compared to a current price of ₹113.30 — trading 33.4% below its estimated fair value. The current Return-on-Tangible-Equity is 4.83%, which is 66% below median its 10-year median of 14.15 and 38.6% below the Drug Manufacturers industry median of 7.87. Panchsheel Organics' overall GF Score™ is 70/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Return-on-Tangible-Equity calculated?
Return-on-Tangible-Equity is calculated from a company's financial statements. For Panchsheel Organics (BOM:531726), the current Return-on-Tangible-Equity is 4.83% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Panchsheel Organics (BOM:531726) Overvalued in 2026?
Based on GuruFocus' analysis, Panchsheel Organics stock appears to be undervalued.
The current stock price of ₹113.30 is trading 33.4% below its estimated GF Value™ of ₹170.04.
GuruFocus considers Panchsheel Organics to be Possible Value Trap.
Key valuation signals for BOM:531726:
Return-on-Tangible-Equity: 4.83% (66% below median its 10-year median of 14.15)
GF Value™: ₹170.04 vs. price of ₹113.30 (33.4% below fair value)
Industry Position: 38.6% below the Drug Manufacturers median (#450 of 899)
No single metric tells the full story. See the BOM:531726 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
AddressProf. N. S. Phadke Marg, 137,138 Hubtown Solaris, 1st Floor, Opposite Teli Gali, Near Andheri East West Flyover, Andheri (East), Mumbai, MH, IND, 400 069
Panchsheel Organics Ltd is an India based pharmaceutical company. It is engaged in the manufacturing and exporting of Active Pharma Ingredients (APIs), intermediates, and finished formulations. The company's product categories include API and intermediaries, Steroids and Hormones, Veterinary Products, OTC Products, Oncology Products, Neutraceutical Products, and Excipients.
70GF Score
Get the complete analysis for BOM:531726
Return-on-Tangible-Equity is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BOM:531726 has been successfully added to your 
